126 related articles for article (PubMed ID: 7629603)
1. Dosimetric models and S factors for radiation doses to the bladder wall in children receiving therapeutic iodine-131-MIBG.
Bolster AA; Hilditch TE; Wheldon TE
J Nucl Med; 1995 Aug; 36(8):1530-1. PubMed ID: 7629603
[No Abstract] [Full Text] [Related]
2. Iodine-125-MIBG therapy for neuroblastoma.
Hoefnagel CA; Smets L; Voûte PA; de Kraku J
J Nucl Med; 1991 Feb; 32(2):361-2. PubMed ID: 1992043
[No Abstract] [Full Text] [Related]
3. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
[TBL] [Abstract][Full Text] [Related]
4. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
Sisson JC; Shapiro B; Hutchinson RJ; Zasadny KR; Mallette S; Mudgett EE; Wieland DM
J Nucl Biol Med (1991); 1991; 35(4):255-9. PubMed ID: 1823830
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
Prog Clin Biol Res; 1991; 366():455-61. PubMed ID: 2068160
[No Abstract] [Full Text] [Related]
6. The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy.
Troncone L; Rufini V; Riccardi R; Lasorella A; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):232-6. PubMed ID: 1823825
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children.
Bolster AA; Hilditch TE; Wheldon TE; Gaze MN; Barrett A
Br J Radiol; 1995 May; 68(809):481-90. PubMed ID: 7788233
[TBL] [Abstract][Full Text] [Related]
8. [Iodobenzylguanide-131 therapy as first choice in non-metastasized neuroblastoma].
De Kraker J; Hoefnagel CA; Caron HN; Vos A; Bras J; Greve JC
Ned Tijdschr Geneeskd; 1996 Oct; 140(40):1997-2000. PubMed ID: 8965930
[TBL] [Abstract][Full Text] [Related]
9. Iodine-125-MIBG to treat neuroblastoma: preliminary report.
Sisson JC; Hutchinson RJ; Shapiro B; Zasadny KR; Normolle D; Wieland DM; Wahl RL; Singer DA; Mallette SA; Mudgett EE
J Nucl Med; 1990 Sep; 31(9):1479-85. PubMed ID: 2395016
[TBL] [Abstract][Full Text] [Related]
10. Session on the treatment of neuroblastoma with radioiodinated metaiodobenzylguanidine. Chairmen's report.
Mastrangelo R; Voûte PA
J Nucl Biol Med (1991); 1991; 35(4):260-2. PubMed ID: 1823831
[No Abstract] [Full Text] [Related]
11. Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.
Klingebiel T; Bruchelt G; Kaleva N; Wollmann H; Handgretinger R; Treuner J; Gupta D; Niethammer D
Prog Clin Biol Res; 1991; 366():509-12. PubMed ID: 2068167
[No Abstract] [Full Text] [Related]
12. Session on the biology and treatment of neuroblastoma as related to metaiodobenzylguanidine. Chairmen's report.
Sisson JC; De Bernardi B
J Nucl Biol Med (1991); 1991; 35(4):199-201. PubMed ID: 1823818
[No Abstract] [Full Text] [Related]
13. Radiolabelled mIBG in the treatment of neuroblastoma.
Gaze MN; Wheldon TE
Eur J Cancer; 1996 Jan; 32A(1):93-6. PubMed ID: 8695251
[No Abstract] [Full Text] [Related]
14. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
[TBL] [Abstract][Full Text] [Related]
15. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children.
Bolster AA; Hilditch TE
Br J Radiol; 1995 Nov; 68(815):1263. PubMed ID: 8542240
[No Abstract] [Full Text] [Related]
17. The therapeutic use of I-131 meta-iodobenzylguanidine (mIBG) in neuroblastoma: a phase II study in 12 patients.
Hartmann O; Lumbroso JD; Lemerle M; Schlumberger M; Ricard M; Aubert B; Coornaert S; Merlin L; Parmentier C
Prog Clin Biol Res; 1988; 271():655-67. PubMed ID: 3043455
[No Abstract] [Full Text] [Related]
18. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma].
Guerra P
Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889
[TBL] [Abstract][Full Text] [Related]
19. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
Klingebiel T; Treuner J; Ehninger G; Keller KD; Dopfer R; Feine U; Niethammer D
Cancer Chemother Pharmacol; 1989; 25(2):143-8. PubMed ID: 2598401
[TBL] [Abstract][Full Text] [Related]
20. Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans.
Hattner RS; Pounds TR; Matthay KK
Clin Nucl Med; 1994 Nov; 19(11):985-8. PubMed ID: 7842595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
